Status:
COMPLETED
Mood Disorders Bladder Cancer
Lead Sponsor:
University of Kansas Medical Center
Conditions:
Bladder Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This is a cross-sectional study evaluating mood disorders in bladder cancer patients and their caregivers across the bladder cancer trajectory
Eligibility Criteria
Inclusion
- Patients or caregiver of patient with a histologic diagnosis of bladder cancer of the following subtypes, urothelial carcinoma, adenocarcinoma, or squamous cell carcinoma, within 24 months of survey administration and received treatment at the University of Kansas Health System
- ≥ 18 years of age
- Have a patient-designated primary informal/family caregiver
- Able to speak and read English
- Willing and able to provide informed consent
- Functioning telephone number or access to one
Exclusion
- Patients or caregivers of patients with metastatic bladder cancer
- Patients who are unable to designate a primary caregiver
- Patients and caregivers who do not both consent to study participation
Key Trial Info
Start Date :
September 19 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 4 2021
Estimated Enrollment :
358 Patients enrolled
Trial Details
Trial ID
NCT04036877
Start Date
September 19 2019
End Date
August 4 2021
Last Update
November 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kansas Health System
Kansas City, Kansas, United States, 66160